Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (155)	12/19/2002 12:15:05 PM
From: Jibacoa	Respond to of 3722

SEPR Is up 23% on volume of 4.8 M (more than 4x its daily average) after it announced early this morning that after recent discussions with the FDA, it intends to submit its NDA for ESTORRA (its brand eszopiclone) for the treatment of insomnia by mid-February 2003. It opened on an up-gap, but so far has not been able to trade above its November 25 intra-day H of 10.70 (Its 9.50AM intra-day H 10.66 and the second attempt at 10.05 AM was cut a penny short at 10.65) siliconinvestor.com The stock has traded above its July 17 H of 10.55 and will see if it can close above that level today.<g> siliconinvestor.com Once over that hurdle, the May 23 H of 14.05 seems to be not a big problem and the stock should be on its way to test the resistance at the 19 level. siliconinvestor.com Bernard

To: Jibacoa who wrote (155)	1/6/2003 12:14:40 PM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

SQNM Is up only 14.99%(It is still 0.01% short of making the Biotech Fireworks list today.<g>) It said on this morning that it expects revenue to rise by nearly 43 percent in 2003 as it attracts more customers by expanding its offerings.(It anticipates reporting revenue of about $32.2M for 2002, with $7.5 M from the 4th Q and for 2003, it expects revenue of $46 M. "New customer applications for the MassARRAY system should help increase sales of our genetic systems unit by approximately 40 percent in 2003," said its CEO Toni Schuh. The company estimated its cash balance at the end of 2002 at about $100 M. (About $2.54/share) SQNM started on a small up-gap siliconinvestor.com It is finding some resistance at the Dec.26 H of $1.85.( It needs to close above the Dec.23-Dec.24 double top at $1.89) siliconinvestor.com I am planning on adding to my position on a close above its Agust 26 H of $2.93 for a test of its March H of $7.66 <g> Bernard